106 related articles for article (PubMed ID: 24628262)
1. Impacts of MR spectroscopic imaging on glioma patient management.
Chronaiou I; Stensjøen AL; Sjøbakk TE; Esmaeili M; Bathen TF
Acta Oncol; 2014 May; 53(5):580-9. PubMed ID: 24628262
[TBL] [Abstract][Full Text] [Related]
2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
3. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
5. [Application of 1H-magnetic resonance spectroscopy in differential diagnosis of brain low-grade gliomas and demyelinating diseases].
Hou XY; Gao PY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):206-9. PubMed ID: 19507601
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
7. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
[TBL] [Abstract][Full Text] [Related]
9. Differentiating intracranial aspergillosis from a high grade glioma using MRI and MR spectroscopic imaging.
Pollack E; Bhaya A; Law M
J Neuroimaging; 2007 Oct; 17(4):361-6. PubMed ID: 17894631
[TBL] [Abstract][Full Text] [Related]
10. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.
Nelson SJ; Graves E; Pirzkall A; Li X; Antiniw Chan A; Vigneron DB; McKnight TR
J Magn Reson Imaging; 2002 Oct; 16(4):464-76. PubMed ID: 12353260
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis.
Gruber S; Stadlbauer A; Mlynarik V; Gatterbauer B; Roessler K; Moser E
Neurosurg Clin N Am; 2005 Jan; 16(1):101-14, vi. PubMed ID: 15561531
[TBL] [Abstract][Full Text] [Related]
12. Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas.
Rao PJ; Jyoti R; Mews PJ; Desmond P; Khurana VG
Br J Neurosurg; 2013 Oct; 27(5):646-53. PubMed ID: 23461752
[TBL] [Abstract][Full Text] [Related]
13. Partially parallel MR spectroscopic imaging of gliomas at 3T.
Ozturk E; Banerjee S; Majumdar S; Nelson SJ
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():493-6. PubMed ID: 17945589
[TBL] [Abstract][Full Text] [Related]
14. Unsupervised nosologic imaging for glioma diagnosis.
Li Y; Sima DM; Van Cauter S; Himmelreich U; Croitor Sava AR; Pi Y; Liu Y; Van Huffel S
IEEE Trans Biomed Eng; 2013 Jun; 60(6):1760-3. PubMed ID: 23192480
[TBL] [Abstract][Full Text] [Related]
15. [The proton MR spectroscopy of intracranial tumors. The differential diagnostic aspects for gliomas, metastases and meningiomas].
Vogl TJ; Jassoy A; Söllner O; Becker C; Hamburger C; Dadashi A; Sauter R; Lissner J
Rofo; 1992 Oct; 157(4):371-7. PubMed ID: 1327273
[TBL] [Abstract][Full Text] [Related]
16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
17. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.
Luyten PR; Marien AJ; Heindel W; van Gerwen PH; Herholz K; den Hollander JA; Friedmann G; Heiss WD
Radiology; 1990 Sep; 176(3):791-9. PubMed ID: 2389038
[TBL] [Abstract][Full Text] [Related]
18. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ
J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
